Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
Maria Cristina Manara(Istituto Ortopedico Rizzoli), Katia Scotlandi(Istituto Ortopedico Rizzoli)
Cited by 14
Related Papers
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
|JAMA Oncology|2020|251
Preclinical <i>In vivo</i> Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma
|Clinical Cancer Research|2007|133
Contribution of MEK/MAPK and PI3‐K signaling pathway to the malignant behavior of Ewing's sarcoma cells: Therapeutic prospects
|International Journal of Cancer|2003|66